Fact CheckerSign in

NCT06590038Completed

Psychotherapy Feasibility Pilot of the Carolina Recovery From Depression Protocol

Psychotherapy Feasibility and Acceptability Pilot of the Carolina Recovery From Depression Protocol (CARED): A Novel Rapid Treatment Paradigm for Depression

Source: ClinicalTrials.gov · Last updated 4 Jun 2025

Brief summary (registry, in English)

The goal of this clinical trial is to learn whether an single session intervention can reduce psychological impairment in adult individuals with moderate depression. The main questions it aims to answer are: Is this evidence-based intervention acceptable to study participants? Is this evidence-based intervention feasible to implement in a single session? Is there evidence that the evidence-based intervention reduces psychological impairment in adults with moderate to severe depression? Participants will complete: * an in-depth diagnostic screening interview prior to enrollment * a set of mental health questionnaires at baseline and two weeks post-intervention * a 3-hour, evidence-based, single session psychotherapeutic intervention with a trained clinician

Status (registry)
Completed
Study type
Interventional
Enrollment
10 (actual)
First submitted
5 Sept 2024
Start date
3 Mar 2025
Primary completion date
24 Apr 2025
Lead sponsor
University of North Carolina, Chapel Hill
Diseases
Depression
NCT number
NCT06590038

What you commit to

  • Study type: Interventional
  • Participants enrolled: 10
  • From 3 Mar 2025 to the primary completion date, 24 Apr 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Any participants taking psychotropic medication must be on a stable dose for at least 4 weeks with no planned dose changes within the next 4 weeks.
  • Participants may not have undergone prior brain surgery
  • Participants may not have any brain devices/implants, including cochlear implants and aneurysm clips

Other illness

  • Participants must not meet criteria for current severe substance use disorder, anorexia nervosa, or active psychosis as assessed by psychodiagnostic assessment
  • Participants may not have any medical or neurological illness for which symptom presentation or treatment could interfere with study participation
  • Participants may not have a history of brain injury requiring current treatment

Other

  • Participants must not have current active suicide intent as determined by the Columbia Suicide Severity Rating Scale (C-SSRS)
  • Participants able to birth must not be pregnant or breastfeeding.
  • Participants may not have had brain injury or concussion within the last three months

Who the study is looking for

  • Age of 18 years or older
  • Able to provide informed consent
  • Willing to comply with all study procedures and be available for the duration of the study
  • Speak and understand English
  • Diagnostic and Statistical Manual (DSM)-5 diagnosis of major depressive disorder (MDD) as confirmed by semi-structured clinical assessment
  • Meet a cutoff of at least a moderate depression score on the Beck Depression Inventory (BDI-II) (≥ 20)

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Carolina Center for Neurostimulation
Coordinator of this site? Confirm its status
Chapel HillUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.